Literature DB >> 28031197

Ciprofloxacin-Mediated Mutagenesis Is Suppressed by Subinhibitory Concentrations of Amikacin in Pseudomonas aeruginosa.

Estela Ynés Valencia1, Fernanda Esposito2, Beny Spira1, Jesús Blázquez3,4, Rodrigo S Galhardo5.   

Abstract

Resistance to antibiotics is a global health problem. Activation of the SOS response, and the subsequent elevation in mutagenesis, contributes to the appearance of resistance mutations. Among currently used drugs, quinolones are the most potent inducers of the SOS response. In the present study, we show that amikacin inhibits ciprofloxacin-mediated SOS induction and mutagenesis in Pseudomonas aeruginosa.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosa; SOS response; ciprofloxacin; recA

Mesh：

Substances：

Year:  2017        PMID： 28031197      PMCID： PMC5328548          DOI： 10.1128/AAC.02107-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  32 in total

Review 1.  Antibiotics and antibiotic resistance: a bitter fight against evolution.

Authors:  Alexandro Rodríguez-Rojas; Jerónimo Rodríguez-Beltrán; Alejandro Couce; Jesús Blázquez
Journal:  Int J Med Microbiol       Date:  2013-03-19       Impact factor: 3.473

2.  Construction of mobilizable mini-Tn7 vectors for bioluminescent detection of gram-negative bacteria and single-copy promoter lux reporter analysis.

Authors:  F Heath Damron; Elizabeth S McKenney; Mariette Barbier; George W Liechti; Herbert P Schweizer; Joanna B Goldberg
Journal:  Appl Environ Microbiol       Date:  2013-04-12       Impact factor: 4.792

3.  Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin.

Authors:  Ryan T Cirz; Bryan M O'Neill; Jennifer A Hammond; Steven R Head; Floyd E Romesberg
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

4.  Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1.

Authors:  Elena B M Breidenstein; Manjeet Bains; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

5.  Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance.

Authors:  Zeynep Baharoglu; Didier Mazel
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

6.  Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.

Authors:  Lorenzo Drago; Elena De Vecchi; Lucia Nicola; Alberto Colombo; Anna Guerra; Maria Rita Gismondo
Journal:  Chemotherapy       Date:  2004-09-23       Impact factor: 2.544

7.  Structural basis for aminoglycoside inhibition of bacterial ribosome recycling.

Authors:  Maria A Borovinskaya; Raj D Pai; Wen Zhang; Barbara S Schuwirth; James M Holton; Go Hirokawa; Hideko Kaji; Akira Kaji; Jamie H Doudna Cate
Journal:  Nat Struct Mol Biol       Date:  2007-07-29       Impact factor: 15.369

8.  Novobiocin Inhibits the Antimicrobial Resistance Acquired through DNA Damage-Induced Mutagenesis in Acinetobacter baumannii.

Authors:  Luis M Jara; María Pérez-Varela; Jordi Corral; Marta Arch; Pilar Cortés; Germán Bou; Jesús Aranda; Jordi Barbé
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

9.  Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.

Authors:  Gamal F Gad; Heba A Mohamed; Hossam M Ashour
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

10.  RpoS plays a central role in the SOS induction by sub-lethal aminoglycoside concentrations in Vibrio cholerae.

Authors:  Zeynep Baharoglu; Evelyne Krin; Didier Mazel
Journal:  PLoS Genet       Date:  2013-04-11       Impact factor: 5.917
View more
  6 in total

1.  Betulinic Acid Prevents the Acquisition of Ciprofloxacin-Mediated Mutagenesis in Staphylococcus aureus.

Authors:  Alexsander Rodrigues Carvalho Junior; Arthur Lima de Berredo Martins; Brenda da Silva Cutrim; Deivid Martins Santos; Hermerson Sousa Maia; Mari Silma Maia da Silva; Adrielle Zagmignan; Maria Raimunda Chagas Silva; Cristina de Andrade Monteiro; Giselle Maria Skelding Pinheiro Guilhon; Antônio José Cantanhede Filho; Luís Cláudio Nascimento da Silva
Journal:  Molecules       Date:  2019-05-07       Impact factor: 4.411

2.  Lying in Wait: Modeling the Control of Bacterial Infections via Antibiotic-Induced Proviruses.

Authors:  Sara M Clifton; Ted Kim; Jayadevi H Chandrashekhar; George A O'Toole; Zoi Rapti; Rachel J Whitaker
Journal:  mSystems       Date:  2019-10-01       Impact factor: 6.496

3.  Expression of different ParE toxins results in conserved phenotypes with distinguishable classes of toxicity.

Authors:  Jessica R Ames; Meenakumari Muthuramalingam; Tamiko Murphy; Fares Z Najar; Christina R Bourne
Journal:  Microbiologyopen       Date:  2019-07-16       Impact factor: 3.139

4.  Rapid microevolution of biofilm cells in response to antibiotics.

Authors:  Anahit Penesyan; Stephanie S Nagy; Staffan Kjelleberg; Michael R Gillings; Ian T Paulsen
Journal:  NPJ Biofilms Microbiomes       Date:  2019-11-06       Impact factor: 7.290

5.  Transcriptomic determinants of the response of ST-111 Pseudomonas aeruginosa AG1 to ciprofloxacin identified by a top-down systems biology approach.

Authors:  José Arturo Molina-Mora; Diana Chinchilla-Montero; Maribel Chavarría-Azofeifa; Alejandro J Ulloa-Morales; Rebeca Campos-Sánchez; Rodrigo Mora-Rodríguez; Leming Shi; Fernando García
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

6.  RecA and Specialized Error-Prone DNA Polymerases Are Not Required for Mutagenesis and Antibiotic Resistance Induced by Fluoroquinolones in Pseudomonas aeruginosa.

Authors:  Jessica Mercolino; Alessandra Lo Sciuto; Maria Concetta Spinnato; Giordano Rampioni; Francesco Imperi
Journal:  Antibiotics (Basel)       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.